← Eichor
Study identifier: NCT07162337 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention

Condition: Colorectal Cancer Prevention · Colorectal Adenoma  ·  Sponsor: Massachusetts General Hospital

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This research study is a prospective, single-arm clinical trial to assess the effect of a dietary intervention for more plant-based and less animal-based food intake on secondary bile acid production, gut microbiota, circulating biomarkers and gene expression associated with colonic bile acid receptor activation and colorectal cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Andrew T. Chan, MD, MPH  ·  617-726-3212  ·  achan@mgh.harvard.edu

Kai Wang, PhD  ·  617-817-9246  ·  kwang41@mgh.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Massachusetts General Hospital Cancer CenterBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07162337